Clinical trial Recruiting at 9 sites Interventional Ages 18 and up

Comparing drug-coated balloons and drug-eluting stents for coronary artery disease

Official title: DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)

Run by Fundación EPIC · NCT06448637 · Data updated 2026-11-12

This study is testing whether a special balloon or a stent works better to improve blood flow in people with coronary artery disease after eight months.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment94 (estimated)
SponsorFundación EPIC
Academic / other
Drugs / interventionsmethotrexate
Locations9 sites (Barcelona and 8 other locations)
StatusRecruiting
StartedOctober 23, 2024
Main results expectedDecember 1, 2026
Study endsDecember 1, 2027
Registry record updatedSeptember 30, 2026
Trial IDNCT06448637 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with chronic or acute coronary syndrome and de novo lesions in large coronary vessels.

Probably not a fit

Patients with contraindications to acetylcholine or nitroglycerin, or those with a history of coronary vasospasm, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study is a randomized, controlled, open-label, multicenter trial that evaluates the vasomotor function of patients with coronary artery disease eight months after treatment with either a drug-coated balloon (DCB) or a drug-eluting stent (DES) in large vessels measuring 3.5 mm or more. The study aims to determine the effectiveness of these two interventions in improving vascular function. Participants will be monitored for their response to treatment and any potential complications. The findings will contribute to understanding the best treatment options for patients with coronary artery disease.

Why it matters

Potential benefit: If successful, this study could provide insights into more effective treatment options for patients with coronary artery disease, potentially improving their vascular health.

How similar studies have gone: Previous studies have shown varying success with drug-coated balloons and drug-eluting stents, but this specific comparative approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients who meet all of the following conditions are included.

* Patients aged ≥ 18 years and;
* Patients with chronic coronary syndrome, acute coronary syndrome without ST segment elevation or acute coronary syndrome with elevation ST segment in non-culprit lesions 48 hours after the event and;
* Patients with de novo lesions in vessels ≥ 3.5 mm without calcification significant no visible thrombus and;
* Patients who have been informed of the characteristics of the study and have provided their written informed consent.

Exclusion Criteria:

Patients who meet at least one of the following conditions are excluded:

* Patients with any contraindication for the administration of acetylcholine (ACh) or nitroglycerin (NTG).
* Patients with a history of coronary vasospasm or spontaneous dissection of the coronary artery.
* Patients with significant medical, surgical or psychiatric condition that would affect the safety of the subject or influence the outcome of the study according to the doctor's opinion.
* Patients who received a combination of DES and DCB in the same vessel
* Patients with glomerular filtration rate \<30 ml/min/ 1.73 m2
* Patients with body mass index \>35 (may affect the evaluation qualitative diameter of the coronary artery).
* Patients with symptomatic congestive heart failure.
* Patients with significant autoimmune inflammatory conditions and patients taking immunomodulatory medications (including methotrexate, cyclosporine, steroids).
* Patients with heart transplant.
* Patients with anemia (Hb \<12 g/dL in men and \<10 g/dL in women).
* Patients, women of childbearing age with a positive pregnancy test.
* Pregnant female patients.
* Patients included in other clinical trials with active follow-up.

Where it's running

  • Hospital Universitari Vall d'Hebron
    Barcelona, Spain
    Recruiting
  • Hospital Universitario de Cabueñes
    Gijón, Spain
    Recruiting
  • Hospital Universitario Juan Ramón Jiménez
    Huelva, Spain
    Recruiting
  • Hospital Universitario de Leon
    León, Spain
    Recruiting
  • Hospital Universitario Lucus Augusti
    Lugo, Spain
    Recruiting
  • Hospital de Merida
    Mérida, Spain
    Recruiting
Show 3 more locations
  • Hospital Universitario Central de Asturias
    Oviedo, Spain
    Recruiting
  • Hospital Provincial de Pontevedra
    Pontevedra, Spain
    Recruiting
  • Hospital Universitari de Tarragona Joan XXIII
    Tarragona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.